Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ALZN
ALZN logo

ALZN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Alzamend Neuro Inc (ALZN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
1.140
1 Day change
52 Week Range
3.600
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

ALZN is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trending weakly, lacks supportive catalysts, has no strong proprietary buy signal, and does not show enough evidence of durable upside. Given the user’s impatience and preference to act now rather than wait for a better entry, the direct call is to avoid buying and not allocate capital here at this time.

Technical Analysis

The technical picture is bearish. MACD histogram is negative and expanding, showing weakening momentum. RSI at 41.76 is neutral-to-weak, not oversold enough to suggest a strong rebound setup. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, indicating the stock is in a downtrend. Price at 1.13 is just above S1 support at 1.101 and above S2 at 1.028, while still below the pivot at 1.22, which reinforces a weak short-term structure. The recent pattern-based trend also only suggests modest probabilities of small gains, not a strong breakout setup.

Positive Catalysts

  • No news in the recent week. There are no notable positive event-driven catalysts, hedge funds are neutral, insiders are neutral, and there is no recent congress trading data to suggest fresh institutional or political conviction. The only mildly constructive point is that price remains above key support near 1.101.

Neutral/Negative Catalysts

  • Recent sentiment is weak: the stock closed down to 1.13 from 1.16, pre-market was down 6.25%, and post-market was down 2.61%, suggesting unstable trading behavior. Technical momentum is bearish, there is no AI Stock Picker signal, and SwingMax shows no recent buy signal. No news means no fresh catalyst to drive sustained upside. Hedge fund and insider activity are both neutral, and there is no congress trading support. The stock also lacks valuation data and a usable latest-quarter financial snapshot, which limits confidence further.

Financial Performance

No latest quarter financial snapshot was available due to data error, so there is no reliable recent revenue or earnings growth picture to support a long-term buy decision. Without visible quarterly fundamentals, the stock cannot be justified as a strong beginner-friendly investment.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no evidence of improving Wall Street sentiment. Based on the available data, Wall Street pros would lean cautious: the bearish technical setup and lack of catalysts are clear cons, while the only pro is that the stock is trading near support and could bounce short term. Overall, the pro case is weak and does not outweigh the risks.

Wall Street analysts forecast ALZN stock price to rise
1 Analyst Rating
Wall Street analysts forecast ALZN stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.140
sliders
Low
28
Averages
28
High
28
Current: 1.140
sliders
Low
28
Averages
28
High
28
No data

No data

People Also Watch